1374657-02-9 Usage
Uses
Used in Organic Synthesis:
4-bromo-1-(oxetan-3-yl)-1H-pyrazole is utilized as a building block in organic synthesis for the creation of various compounds. Its distinctive structure allows for the development of molecules with a wide range of applications.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 4-bromo-1-(oxetan-3-yl)-1H-pyrazole is employed as a key intermediate for the synthesis of pharmaceutical compounds. Its reactivity and structural features are harnessed to design and produce new drugs with potential therapeutic benefits.
Used in Agrochemical Development:
4-bromo-1-(oxetan-3-yl)-1H-pyrazole also serves as a crucial component in the development of agrochemicals. Its integration into the synthesis process can lead to the creation of novel compounds with applications in agriculture, such as pesticides or herbicides, aimed at enhancing crop protection and yield.
Used in Research and Development:
4-bromo-1-(oxetan-3-yl)-1H-pyrazole is further used in research and development initiatives, where its properties are explored to discover new drugs or agrochemicals. This exploration is vital for expanding the scope of available treatments in healthcare and improving agricultural practices.
Check Digit Verification of cas no
The CAS Registry Mumber 1374657-02-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,7,4,6,5 and 7 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1374657-02:
(9*1)+(8*3)+(7*7)+(6*4)+(5*6)+(4*5)+(3*7)+(2*0)+(1*2)=179
179 % 10 = 9
So 1374657-02-9 is a valid CAS Registry Number.
1374657-02-9Relevant articles and documents
PYRROLE COMPOUNDS, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
-
Paragraph 0326, (2015/02/19)
Compounds of formula (I): wherein A1, A2, Ra, Rb, Rc, Rd, R3, R4, R5 and T are as defined in the description. Medicinal products containing the same which are useful in treating pathologies involving a deficit in apoptosis, such as cancer, auto-immune diseases, and diseases of the immune system.
N-ACYLPIPERIDINE ETHER TROPOMYOSIN-RELATED KINASE INHIBITORS
-
Page/Page column 192, (2015/07/07)
The present invention relates to compounds of Formula (I) described herein and their pharmaceutically acceptable salts, and their use in medicine, in particular as Trk antagonists.